These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1254 related items for PubMed ID: 21435154
1. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ. BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [Abstract] [Full Text] [Related]
2. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clin Cancer Res; 2005 Jul 15; 11(14):5128-39. PubMed ID: 16033827 [Abstract] [Full Text] [Related]
4. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR. Gene; 2011 Dec 10; 489(2):63-9. PubMed ID: 21925246 [Abstract] [Full Text] [Related]
5. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J. BJU Int; 2012 May 10; 109(10):1565-70. PubMed ID: 21981759 [Abstract] [Full Text] [Related]
6. Gene signatures of progression and metastasis in renal cell cancer. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA. Clin Cancer Res; 2005 Aug 15; 11(16):5730-9. PubMed ID: 16115910 [Abstract] [Full Text] [Related]
7. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. Clin Biochem; 2010 Jan 15; 43(1-2):150-8. PubMed ID: 19646430 [Abstract] [Full Text] [Related]
12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. Int J Oncol; 2006 Oct 15; 29(4):799-827. PubMed ID: 16964377 [Abstract] [Full Text] [Related]
16. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, Milione M, Bhakta V, Campanini N, Swift SM, Bordi C, Delle Fave G, Lemoine NR. Endocr Relat Cancer; 2006 Jun 15; 13(2):541-58. PubMed ID: 16728581 [Abstract] [Full Text] [Related]
17. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. He H, Zhou GX, Zhou M, Chen L. Int J Gynecol Pathol; 2011 Sep 15; 30(5):425-30. PubMed ID: 21804394 [Abstract] [Full Text] [Related]
18. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M. BJU Int; 2008 Nov 15; 102(10):1381-4. PubMed ID: 18782311 [Abstract] [Full Text] [Related]